| Product Code: ETC7471983 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Hong Kong`s apremilast import market saw a diverse range of top exporting countries, including Ireland, Belgium, China, Germany, and Singapore. Despite this variety, the market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 11.25%, indicating sustained market expansion. Additionally, the growth rate from 2023 to 2024 was 3.57%, suggesting a steady uptrend in import volumes for apremilast in Hong Kong.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong Apremilast Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong Apremilast Market Revenues & Volume, 2021 & 2031F |
3.3 Hong Kong Apremilast Market - Industry Life Cycle |
3.4 Hong Kong Apremilast Market - Porter's Five Forces |
3.5 Hong Kong Apremilast Market Revenues & Volume Share, By Strength, 2021 & 2031F |
3.6 Hong Kong Apremilast Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Hong Kong Apremilast Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Hong Kong Apremilast Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Hong Kong Apremilast Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.10 Hong Kong Apremilast Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Hong Kong Apremilast Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Hong Kong Apremilast Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriasis and psoriatic arthritis in Hong Kong |
4.2.2 Growing awareness about the benefits of apremilast in treating psoriasis and psoriatic arthritis |
4.2.3 Favorable government regulations and policies supporting the use of apremilast |
4.3 Market Restraints |
4.3.1 High cost associated with apremilast treatment |
4.3.2 Limited availability of healthcare professionals trained in prescribing apremilast in Hong Kong |
5 Hong Kong Apremilast Market Trends |
6 Hong Kong Apremilast Market, By Types |
6.1 Hong Kong Apremilast Market, By Strength |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong Apremilast Market Revenues & Volume, By Strength, 2021- 2031F |
6.1.3 Hong Kong Apremilast Market Revenues & Volume, By 10mg, 2021- 2031F |
6.1.4 Hong Kong Apremilast Market Revenues & Volume, By 20mg, 2021- 2031F |
6.1.5 Hong Kong Apremilast Market Revenues & Volume, By 30mg, 2021- 2031F |
6.2 Hong Kong Apremilast Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Hong Kong Apremilast Market Revenues & Volume, By Antirheumatics, 2021- 2031F |
6.2.3 Hong Kong Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Hong Kong Apremilast Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Hong Kong Apremilast Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Hong Kong Apremilast Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Hong Kong Apremilast Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Hong Kong Apremilast Market Revenues & Volume, By Psoriasis, 2021- 2031F |
6.4.3 Hong Kong Apremilast Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.4.4 Hong Kong Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Hong Kong Apremilast Market, By Dosage Form |
6.5.1 Overview and Analysis |
6.5.2 Hong Kong Apremilast Market Revenues & Volume, By Tablet, 2021- 2031F |
6.5.3 Hong Kong Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Hong Kong Apremilast Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Hong Kong Apremilast Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Hong Kong Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Hong Kong Apremilast Market, By End-Users |
6.7.1 Overview and Analysis |
6.7.2 Hong Kong Apremilast Market Revenues & Volume, By Clinic, 2021- 2031F |
6.7.3 Hong Kong Apremilast Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7.4 Hong Kong Apremilast Market Revenues & Volume, By , 2021- 2031F |
6.8 Hong Kong Apremilast Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 Hong Kong Apremilast Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.8.3 Hong Kong Apremilast Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.8.4 Hong Kong Apremilast Market Revenues & Volume, By , 2021- 2031F |
7 Hong Kong Apremilast Market Import-Export Trade Statistics |
7.1 Hong Kong Apremilast Market Export to Major Countries |
7.2 Hong Kong Apremilast Market Imports from Major Countries |
8 Hong Kong Apremilast Market Key Performance Indicators |
8.1 Number of new patients prescribed apremilast |
8.2 Patient adherence and compliance rates to apremilast treatment |
8.3 Number of healthcare providers attending apremilast training workshops |
9 Hong Kong Apremilast Market - Opportunity Assessment |
9.1 Hong Kong Apremilast Market Opportunity Assessment, By Strength, 2021 & 2031F |
9.2 Hong Kong Apremilast Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Hong Kong Apremilast Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Hong Kong Apremilast Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Hong Kong Apremilast Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.6 Hong Kong Apremilast Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Hong Kong Apremilast Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Hong Kong Apremilast Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Hong Kong Apremilast Market - Competitive Landscape |
10.1 Hong Kong Apremilast Market Revenue Share, By Companies, 2024 |
10.2 Hong Kong Apremilast Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here